Do hypothyroid states and low T3 reduce insulin sensitivity and alter hepatic glucose metabolism?

Evidence from clinical and mechanistic studies establishes a strong association between hypothyroid states, low circulating triiodothyronine (T3) levels, and significant disruptions in both systemic insulin sensitivity and hepatic glucose regulation.

Clinical and effectiveness evidence

Low thyroid function, even within the subclinical range, is a recognized driver of metabolic dysfunction.

• Insulin Resistance Prevalence: Research indicates that insulin resistance (measured via HOMA-IR) is present in approximately 43.7% of patients with overt hypothyroidism.
• T3 Correlation: A significant relationship exists even in euthyroid individuals; those in the lowest tertile of free T3 (fT3) levels exhibit a 1.5 times higher risk of insulin resistance (OR 1.52, 95% CI: 1.18–1.95) compared to those in the highest tertile.
• Hepatic Impact: Patients with low thyroid function show significantly higher rates of hepatic steatosis and altered glucose-6-phosphate flux. This manifests as a failure of the liver to properly suppress glucose production (gluconeogenesis) following a meal.

Mechanistic explanations

The metabolic impairment seen in low T3 states is driven by specific genomic and molecular pathways:

• Peripheral Glucose Uptake: T3 is a critical regulator of the GLUT4 gene. Lower T3 levels reduce the expression of GLUT4 glucose transporters in skeletal muscle, directly hindering the body's ability to clear glucose from the bloodstream.
• Hepatic Signaling: In the liver, T3 deficiency disrupts Thyroid Hormone Receptor beta (TRβ) signaling. This disruption impairs the PI3K/Akt pathway, which is essential for insulin to signal the liver to stop producing glucose.
• Enzymatic Dysregulation: Low T3 leads to the dysregulation of key enzymes, including phosphoenolpyruvate carboxykinase (PEPCK) and glucose-6-phosphatase (G6Pase), which control the rate of gluconeogenesis and glycogenolysis.
• Mitochondrial Function: Hypothyroidism impairs mitochondrial biogenesis and increases oxidative stress in myocytes, further reducing the efficiency of insulin-mediated glucose metabolism.

Bottom line

Hypothyroid states and low T3 are strongly associated with reduced insulin sensitivity and altered hepatic glucose metabolism. This occurs through a combination of reduced GLUT4 transporter expression in muscle and impaired insulin signaling in the liver, leading to inefficient glucose uptake and excessive hepatic glucose production.